ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

An Earmark For Pancreatic Cancer

August 3, 2012

NCI Won’t Recognize Wolmark Wile NSABP is Plaintiff In Suit

November 18, 1994

RFA On Pathology Training Released

February 1, 1980

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

January 16, 2009

Avon to Support Community Programs

January 7, 1994

Study Needs 23,000 Women Whose Sisters Have Cancer

September 29, 2006